We serve Chemical Name:samarium(iii) chloride hexahydrate CAS:13465-55-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:samarium(iii) chloride hexahydrate
CAS.NO:13465-55-9
Synonyms:Trichlorosamarium hexahydrate;EINECS 233-797-0;MFCD00149859;Samarium chloride hexahydrate;samarium(3+),trichloride,hexahydrate;Samarium trichloride hydrate
Molecular Formula:H12Cl3O6Sm
Molecular Weight:364.811
HS Code:
Physical and Chemical Properties:
Melting point:686ºC
Boiling point:N/A
Density:2.383 g/mL at 25 °C(lit.)
Index of Refraction:
PSA:55.38000
Exact Mass:364.889648
LogP:1.68270
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like Trichlorosamarium hexahydrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Samarium trichloride hydrate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00149859 Use and application,Trichlorosamarium hexahydrate technical grade,usp/ep/jp grade.
Related News: Biocatalysis is widely recognized to be one of the most powerful tools for organic synthesis due to its green credentials and its exquisite regio-, enantio-, and stereoselectivities. triacont-1-ene manufacturers Another critically important benefit of biocatalytic processes is that they are far more eco-efficient than conventional methods. This is because enzymes, being originally derived from natural products, generally perform best under mild (often ambient) conditions. 3-Amino-5-methoxyisonicotinic acid suppliers Bluebird also earned an approval Wednesday in Europe for its gene therapy Lenti-D for children with early cerebral adrenoleukodystrophy and an ABCD1 genetic mutation without a matched sibling donor. 1-epi-Calcitriol vendor & factory So-called “off” periods occur when a Parkinson’s patient has difficulty moving about and occur when the effect of the last dose of another common Parkinson’s drug, known as levodopa, wears off.,He further explained that getting a new drug to commercial manufacturing is also complex and costly due to the very stringent drug manufacturing regulatory mechanism.
